📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

CRISPR-Cas9 correction of OPA1 c.1334G>A: p.R445H restores mitochondrial homeostasis in dominant optic atrophy patient-derived iPSCs. (2021)

First Author: Sladen PE

Attributed to: Novel therapeutic approaches to rescue retinal dysfunction in patient-derived photoreceptors funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.omtn.2021.08.015

PubMed Identifier: 34589289

Publication URI: http://europepmc.org/abstract/MED/34589289

Type: Journal Article/Review

Volume: 26

Parent Publication: Molecular therapy. Nucleic acids

ISSN: 2162-2531